RUNX2 and chronic kidney disease: In agreement with the results of the PPI analysis, USP47 may mediate osteogenic transdifferentiation markers, such as RUNX2, Klotho, FGF23, and MGP, through the BTRC/AKT1 pathway upon CKD vascular calcification.